Algorithmic Bias in AI-Based Diabetes Care: Systematic Review of Model Performance, Equity Reporting, and Physiological Label Bias

سال انتشار: 1404
محل انتشار: InfoScience Trends، دوره: 2، شماره: 5
کد COI اختصاصی: JR_ISJTREND-2-5_005
زبان مقاله: انگلیسی
تعداد مشاهده: 10

نویسندگان

Endocrine Research Center, Institute of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Abolfazl Alipour

Student Research Committee, Babol University of Medical Sciences, Babol, Iran

چکیده

Artificial intelligence (AI) and machine learning (ML) have revolutionized diabetes management through glucose prediction and decision-support systems. However, concerns persist about algorithmic bias and demographic disparities in these technologies, particularly across racial, ethnic, and socioeconomic subgroups. This systematic review evaluates the equity of AI-based glucose prediction models, focusing on performance disparities, fairness reporting, and physiological label biases. We conducted a systematic review following the PRISMA ۲۰۲۰ guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Searches were performed in PubMed, Scopus, and Google Scholar using keywords related to AI, diabetes management, and health disparities. Inclusion criteria encompassed studies examining AI/ML models for glucose prediction or nutrition recommendations in diabetes, with a focus on racial, ethnic, or socioeconomic disparities. Data extraction and quality assessment were performed independently by two reviewers. Among ۱,۲۴۳ initially identified articles, only ۱۰ met inclusion criteria. The review revealed limited evidence of subgroup performance disparities, with just one study explicitly evaluating racial differences in AI model performance. Fairness reporting was rare, with only ۷% of AI diabetes studies documenting ethnoracial data and virtually none conducting fairness audits. Physiological and label biases, such as HbA۱c discrepancies between racial groups, were documented but unaddressed in AI model development. AI-based diabetes technologies lack robust equity evaluation, with minimal reporting on subgroup performance and fairness. Without systematic bias mitigation and equitable design, these tools risk exacerbating existing health disparities. Future research must prioritize transparency, representativeness, and fairness to ensure equitable benefits for all populations.

کلیدواژه ها

Artificial intelligence, Algorithmic Bias, Diabetes Management, Health Disparities, Glucose Prediction

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.